Elivex Therapeutics Shares Are Trading Higher After the Company Announced Interim Efficacy Data Showing Statistical Significance and Marked Improvements for Its Allocetra Trial.
Elivex Therapeutics Shares Are Trading Higher After the Company Announced Interim Efficacy Data Showing Statistical Significance and Marked Improvements for Its Allocetra Trial.
Elivex Therapeutics股票上漲，因公司宣佈中期有效性數據顯示統計學顯著性，並對其Allocetra試驗的改善進行了標記。
Elivex Therapeutics Shares Are Trading Higher After the Company Announced Interim Efficacy Data Showing Statistical Significance and Marked Improvements for Its Allocetra Trial.
Elivex Therapeutics的股票在公司宣佈其Allocetra試驗的中期療效數據後上漲，數據顯示統計顯著性和顯著改善。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。